All oral antidiabetic therapies should be discontinued in diabetic patients with severe COVID-19 infection requiring ICU admission.
ATTENTION! Kindly note that if you were in attendance of the live webinar you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Quiz-summary
0 of 5 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
Information
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
Thank you, we will review your submission and notify you of your results via email.
If not received within 5 hours due to spam, don’t worry, it will show in your profile.
- 1
- 2
- 3
- 4
- 5
- Answered
- Review
- Question 1 of 5
1. Question
1. In the diabetic patient, which of the listed factors may contribute to fluid retention?
- Question 2 of 5
2. Question
2. In the patient with diabetes and renal disease, risk of hyperkalaemia can be lowered best by using which combinations of diuretic?
- Question 3 of 5
3. Question
3. The poorly controlled T2DM patient infected with COVID-19 has a ___% increased risk of dying from COVID-19?
- Question 4 of 5
4. Question
4. Which of the listed oral antidiabetic agents is contraindicated for use In diabetic patients with mild COVID-19 disease?
- Question 5 of 5
5. Question
5. Which statement is incorrect?
Do you like this? Share with a colleague
[DISPLAY_ULTIMATE_SOCIAL_ICONS]